Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor Cancer
- First Posted Date
- 2020-05-15
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Immunolight, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04389281
- Locations
- 🇺🇸
Sibley Hospital - Johns Hopkins University, Washington, District of Columbia, United States
🇺🇸Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸Duke University, Durham, North Carolina, United States
News
No news found